A NicOx spokeswoman declines to comment, while Pfizer officials cannot be immediately reached for comment.
Around midday, trading volumes on NicOx shares represent nearly four times the stock's daily average volume of the past three months.
The stock has surged 38 percent since mid-November.
Join the Conversation